American States Water Company (NYSE:
AWR
) is expected to post its Q4 EPS at $0.40 on revenue of $104.35 million. FuelCell Energy Inc (NASDAQ:
FCEL
) to post a FQ1 loss of $0.06 per share on revenue of $32.7 million. Carmike Cinemas Inc (NASDAQ:
CKEC
) is projected to post its Q4 EPS at $0.05 on revenue of $112.20 million. Alexza Pharmaceuticals Inc (NASDAQ:
ALXA
) is estimated to post a Q4 loss at $0.12 per share on revenue of $5.80 million. LDK Solar Co Inc (NYSE:
LDK
) is expected to post a Q4 loss at $0.67 per share on revenue of $424.78 million. IDT Corporation (NYSE:
IDT
) is projected to post its Q2 EPS at $0.06 on revenue of $379.15 million. Coleman Cable Inc (NASDAQ:
CCIX
) is expected to post its Q4 EPS at $0.23 on revenue of $204.19 million. WCA Waste Corporation (NASDAQ:
WCAA
) is estimated to post its Q4 EPS at $0.00 on revenue of $69.15 million. Miller Energy Resourses Inc (NYSE:
MILL
) is projected to post a Q3 loss at $0.15 per share. Ecology and Environment Inc (NASDAQ:
EEI
) is estimated to post its Q2 EPS at $0.35 on revenue of $42.67 million. Kennedy-Wilson Holdings Inc (NYSE:
KW
) is expected to post its Q4 EPS at $0.09 on revenue of $29.94 million. NuPathe Inc (NASDAQ:
PATH
) is estimated to post a Q4 loss at $0.50 per share. Citizens Inc (NYSE:
CIA
) is projected to post its Q4 EPS at $0.04 on revenue of $51.60 million. American Oriental Bioengineering Inc (NYSE:
AOB
) is expected to post its Q4 EPS at $0.10 on revenue of $73.08 million. Douglas Dynamics Inc (NYSE:
PLOW
) is estimated to post its Q4 EPS at $0.22 on revenue of $48.83 million. Omeros Corporation (NASDAQ:
OMER
) is projected to post a Q4 loss at $0.38 per share on revenue of $760.00 thousand. Hallmark Financial Services Inc (NASDAQ:
HALL
) is expected to post a Q4 loss at $0.10 per share on revenue of $67.33 million. Ascent Solar Technologies Inc (NASDAQ:
ASTI
) is projected to post a Q4 loss at $0.14 per share on revenue of $1.20 million. Enzo Biochem Inc (NYSE:
ENZ
) is estimated to post a Q2 loss at $0.06 per share. BioSante Pharmaceuticals Inc (NASDAQ:
BPAX
) is expected to post a Q4 loss at $0.11 per share on revenue of $70.00 thousand. Antares Pharma Inc (AMEX:
AIS
) is estimated to post its Q4 earnings at $0.00 per share.
Market News and Data brought to you by Benzinga APIs

Comments
Loading...